GlassScriptPhysician profile
Sanjayanth Reddy Chamakura
NPI 1659368728
$21,508.36
in general payments reported to CMS, 2019-2025
42 companies · $11K in 2025
The $11K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,090 · 2020: $1,411 · 2021: $823 · 2022: $1,953 · 2023: $1,372 · 2024: $969 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,977 · Food and Beverage: $4,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,976.90 |
| Food and Beverage | $4,253.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,058.72 | 2021-2025 | Onyx Frontier, Venaseal, Symplicity G3 |
| Medtronic Vascular, INC. | $3,419.09 | 2019-2020 | |
| Abbott Laboratories | $1,030.29 | 2019-2024 | Optis, Coroflow, Diamondback Coronary |
| Novartis Pharmaceuticals Corporation | $497.89 | 2019-2024 | |
| Cardiovascular Systems INC. | $419.58 | 2019-2023 | Diamondback Coronary |
| Astrazeneca Pharmaceuticals LP | $388.88 | 2019-2023 | Farxiga |
| Edwards Lifesciences Corporation | $288.72 | 2019-2020 | |
| Boston Scientific Corporation | $288.06 | 2020-2025 | Avvigo Guidance System, Watchman Access System, Eluvia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $258.01 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $251.71 | 2019-2025 | Camzyos |
| Amgen INC. | $237.51 | 2019-2024 | Repatha |
| Merck Sharp & Dohme LLC | $202.84 | 2022-2023 | Verquvo |
| Shockwave Medical, INC | $191.91 | 2019-2022 | |
| Heartflow, INC. | $182.14 | 2025 | |
| Sanofi-Aventis U.S. LLC | $179.41 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjayanth Chamakura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.